Cataleptic effects of γ-hydroxybutyrate (GHB) and baclofen in mice: Mediation by GABAB receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists

Psychopharmacology

Volumn 199, Issue 2, 2008, Pages 191-198

  Koek, Wouter ^a   France, Charles P ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Baclofen; Catalepsy; GABA B; GHB; Glutamate; Ketamine; Mice; MK 801; NMDA; PCP

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 HYDROXYBUTYRIC ACID; BACLOFEN; DIZOCILPINE; GLUTAMIC ACID; KETAMINE; N METHYL DEXTRO ASPARTIC ACID; PHENCYCLIDINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; ATAXIA; CATALEPSY; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANESTHETICS, INTRAVENOUS; ANIMALS; AREA UNDER CURVE; ATAXIA; BACLOFEN; CATALEPSY; DATA INTERPRETATION, STATISTICAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; MALE; MICE; MICE, INBRED C57BL; MUSCLE RELAXANTS, CENTRAL; PHENCYCLIDINE; RECEPTORS, GABA-B; RECEPTORS, N-METHYL-D-ASPARTATE; SODIUM OXYBATE;

EID: 46649116263     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1160-5     Document Type: Article

References (48)

1. Amphoux A, Vialou V, Drescher E, Brüss M, Mannoury La Cour C, Rochat C, Millan MJ, Giros B, Bönisch H, Gautron S (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50:941-952
2. Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P, Vincendon G, Maitre M (1982) High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci 30:953-961
3. Bonanno G, Raiteri M (1992) Functional evidence for multiple gamma-aminobutyric acid B receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther 262:114-118
4. Carai MA, Colombo G, Brunetti G, Melis S, Serra S, Vacca G, Mastinu S, Pistuddi AM, Solinas C, Cignarella G, Minardi G, Gessa GL (2001) Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol 428:315-321
5. Carter LP, Flores LR, Wu H, Chen W, Unzeitig AW, Coop A, France CP (2003) The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. J Pharmacol Exp Ther 305:668-674
6. Carter LP, Wu H, Chen W, Cruz CM, Lamb RJ, Koek W, Coop A, France CP (2004) Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors. J Pharmacol Exp Ther 308:182-188
7. Carter LP, Wu H, Chen W, Matthews MM, Mehta AK, Hernandez RJ, Thomson JA, Ticku MK, Coop A, Koek W, France CP (2005) Novel {gamma}-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists. J Pharmacol Exp Ther 313:1314-1323
8. Carter LP, Chen W, Coop A, Koek W, France CP (2006) Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348. Eur J Pharmacol 538:85-93
9. Colombo G, Agabio R, Lobina C, Reali R, Gessa GL (1998) Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid. Physiol Behav 64:293-302
10. Coughenour LL, Mclean JR, Parker RB (1977) A new device for the rapid measurement of impaired motor function in mice. Pharmacol Biochem Behav 6:351-353
11. Cruz HG, Ivanova T, Lunn ML, Stoffel M, Slesinger PA, Lüscher C (2004) Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat Neurosci 7:153-159
12. Fassio A, Bonanno G, Cavazzani P, Raiteri M (1994) Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor. Eur J Pharmacol 263:311-314
13. Fuller DE, Hornfeldt CS (2003) From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy. Pharmacotherapy 23:1205-1209
14. Gonzalez A, Nutt DJ (2005) Gamma hydroxy butyrate abuse and dependency. J Psychopharmacol 19:195-204
15. Goodwin AK, Froestl W, Weerts EM (2005) Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons. Psychopharmacology (Berl) 180:342-351
16. Itzhak Y, Ali SF (2002) Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann N Y Acad Sci 965:451-460
17. Johnson KM, Snell LD (1985) Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding. Pharmacol Biochem Behav 22:731-735
18. Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der PH, Mosbacher J, Brauner-Osborne H, Waldmeier P, Bettler B (2003) Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 18:2722-2730
19. Koek W, Colpaert FC (1990) Selective blockade of N-methyl-d-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 252:349-357
20. Koek W, Woods JH, Colpaert FC (1990) N-Methyl-d-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis. J Pharmacol Exp Ther 253:1017-1025
21. Koek W, Flores LR, Carter LP, Lamb RJ, Chen W, Wu H, Coop A, France CP (2004) Discriminative stimulus effects of gamma-hydroxybutyrate in pigeons: role of diazepam-sensitive and -insensitive GABA(A) and GABA(B) receptors. J Pharmacol Exp Ther 308:904-911
22. Koek W, Wu H, Coop A, France CP (2006) Discriminative stimulus effects of gamma-hydroxybutyrate: role of training dose. J Pharmacol Exp Ther 317:1-9
23. Koek W, Khanal M, France CP (2007a) Synergistic interactions between 'club drugs': gamma-hydroxybutyrate and phencyclidine enhance each other's discriminative stimulus effects. Behav Pharmacol 18:807-810
24. Koek W, Mercer SL, Coop A (2007b) Cataleptic effects of g-hydroxybutyrate (GHB), its precursor g-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348. Psychopharmacology 192:407-414
25. Lanza M, Fassio A, Gemignani A, Bonanno G, Raiteri M (1993) CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur J Pharmacol 237:191-195
26. Li Q, Kuhn CM, Wilson WA, Lewis DV (2007) Effects of gamma hydroxybutyric acid on inhibition and excitation in rat neocortex. Neuroscience 150:82-92
27. Lingenhoehl K, Brom R, Heid J, Beck P, Froestl W, Kaupmann K, Bettler B, Mosbacher J (1999) Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology 38:1667-1673
28. Maitre M (1997) The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337-361
29. Mamelak M, Escriu JM, Stokan O (1977) The effects of gamma- hydroxybutyrate on sleep. Biol Psychiatry 12:273-288
30. Mathivet P, Bernasconi R, De BJ, Marescaux C, Bittiger H (1997) Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist. Eur J Pharmacol 321:67-75
31. Maurice T, Vignon J (1990) In vivo labeling of phencyclidine (PCP) receptors with 3H-TCP in the mouse brain. J Neurosci Res 26:377-385
32. Mehta AK, Ticku MK (1987) Baclofen induces catatonia in rats. Neuropharmacology 26:1419-1423
33. Navarro JF, Pedraza C, Martin M, Manzaneque JM, Davila G, Maldonado E (1998) Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration. Prog Neuropsychopharmacol Biol Psychiatry 22:835-844
34. Poldrugo F, Addolorato G (1999) The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies. Alcohol Alcohol 34:15-24
35. Rodgers J, Ashton CH, Gilvarry E, Young AH (2004) Liquid ecstasy: a new kid on the dance floor. Br J Psychiatry 184:104-106
36. Seabrook GR, Howson W, Lacey MG (1990) Electrophysiological characterization of potent agonists and antagonists at pre- and postsynaptic GABAB receptors on neurones in rat brain slices. Br J Pharmacol 101:949-957
37. Sevak RJ, France CP, Koek W (2004) Neuroleptic-like effects of gamma-hydroxybutyrate: interactions with haloperidol and dizocilpine. Eur J Pharmacol 483:289-293
38. Sevak RJ, Koek W, France CP (2005) Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy. Eur J Pharmacol 517:64-67
39. Snead OC III, Liu CC (1984) Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem Pharmacol 33:2587-2590
40. Snell LD, Yi SJ, Johnson KM (1988) Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release. Eur J Pharmacol 145:223-226
41. Tunnicliff G, Raess BU (2002) Gamma-hydroxybutyrate (orphan medical). Curr Opin Investig Drugs 3:278-283
42. Waldmeier PC (1991) The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis. Naunyn-Schmiedebergs Arch Pharmacol 343:173-178
43. Weerts EM, Froestl W, Kaminski BJ, Griffiths RR (2007) Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons. Drug Alcohol Depend 89:206-13
44. Winter JC (1981) The stimulus properties of gamma-hydroxybutyrate. Psychopharmacology (Berl) 73:372-375
45. Wong EHF, Knight AR, Woodruff GN (1988) (3H)MK-801 labels a site on the N-methyl-d-asparate receptor channel complex in rat brain membranes. J Neurochem 50:274-281
46. Wong CG, Gibson KM, Snead OC III (2004) From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 25:29-34
47. Wullner U, Klockgether T, Schwarz M, Sontag KH (1987) Behavioral actions of baclofen in the rat ventromedial thalamic nucleus: antagonism by delta-aminovalerate. Brain Res 422:129-136
48. Yamada K, Yu B, Gallagher JP (1999) Different subtypes of GABAB receptors are present at pre- and postsynaptic sites within the rat dorsolateral septal nucleus. J Neurophysiol 81:2875-2883